CNR Institutional Research Information System

CATALUCCI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.642
NA - Nord America 934
EU - Europa 431
SA - Sud America 270
AF - Africa 34
Totale 3.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 885
SG - Singapore 660
CN - Cina 441
BR - Brasile 213
VN - Vietnam 161
IT - Italia 138
HK - Hong Kong 130
FR - Francia 85
KR - Corea 77
NL - Olanda 74
BD - Bangladesh 44
JP - Giappone 36
FI - Finlandia 28
IN - India 27
GB - Regno Unito 26
AR - Argentina 24
DE - Germania 20
MX - Messico 13
CA - Canada 12
ID - Indonesia 12
ZA - Sudafrica 11
EC - Ecuador 10
CR - Costa Rica 8
IL - Israele 8
MA - Marocco 8
PL - Polonia 8
AT - Austria 7
TR - Turchia 7
PK - Pakistan 6
UA - Ucraina 6
CL - Cile 5
IE - Irlanda 5
PE - Perù 5
SE - Svezia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
NP - Nepal 3
PH - Filippine 3
RU - Federazione Russa 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 3.311
Salva come PNG Salva come JPEG
Città #
Singapore 393
Santa Clara 275
Hefei 185
Hong Kong 128
Ashburn 87
Beijing 85
San Jose 84
Seoul 77
Lauterbourg 67
Ho Chi Minh City 60
Los Angeles 49
Hanoi 34
New York 25
Tokyo 24
Dallas 23
Milan 22
Lappeenranta 19
Orem 15
Pisa 14
Buffalo 13
São Paulo 13
Council Bluffs 12
Bologna 11
Frankfurt am Main 10
Minamishinagawa 10
Cagliari 9
Da Nang 9
Rio de Janeiro 9
Denver 8
Helsinki 8
Warsaw 8
Atlanta 7
Querétaro 7
Brescia 6
Chennai 6
Johannesburg 6
Rome 6
San José 6
Vienna 6
Amsterdam 5
Bengaluru 5
Brooklyn 5
Chicago 5
Curitiba 5
Guayaquil 5
Montreal 5
Phoenix 5
Poplar 5
Porto Alegre 5
Belo Horizonte 4
Brasília 4
Dublin 4
Düsseldorf 4
Houston 4
Hyderabad 4
Jakarta 4
Lima 4
Marseille 4
Naples 4
Queens 4
Quito 4
Salvador 4
San Francisco 4
Stockholm 4
Amman 3
Assemini 3
Boardman 3
Brussels 3
Budapest 3
Bắc Ninh 3
Campinas 3
Cape Town 3
Casablanca 3
Charlotte 3
City of London 3
Faenza 3
Guangzhou 3
Guiyang 3
Haiphong 3
Kyiv 3
London 3
Mumbai 3
Piscataway 3
Quảng Ngãi 3
Quận Một 3
San Antonio 3
Tashkent 3
Thái Nguyên 3
Wuppertal 3
Ankara 2
Annapolis 2
Ascoli Piceno 2
Athens 2
Baku 2
Banda Aceh 2
Bari 2
Benevento 2
Bradenton 2
Bridgetown 2
Cachoeiro de Itapemirim 2
Totale 2.043
Salva come PNG Salva come JPEG
Nome #
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 118
Calcium Phosphate Nanoparticle Precipitation by a Continuous Flow Process: A Design of an Experiment Approach 98
Calcium Phosphate Nanoparticles as Carriers of Therapeutic Peptides 96
T cell costimulation blockade blunts pressure overload-induced heart failure 91
Bio-Inspired Negatively-Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs 83
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 82
Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires 81
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. 80
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 79
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 78
Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections 74
Peptidomimetic Targeting of Cav?2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 67
Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure 67
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 66
Inhalation of peptide-loaded nanoparticles improves heart failure 66
MicroRNA-133 Controls Vascular Smooth Muscle Cell Phenotypic Switch In Vitro and Vascular Remodeling In Vivo 65
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 62
The noncoding-RNA landscape in cardiovascular health and disease 60
Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review 60
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 60
MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. 60
Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells 59
MODULATION OF LTCC PATHWAYS BY A MELUSIN MIMETIC INCREASES VENTRICULAR CONTRACTILITY DURING LPS-INDUCED CARDIOMYOPATHY 59
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 58
Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload 58
Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases 56
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug ... 55
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 55
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis 51
Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System 49
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases 48
Disease modeling of a mutation in a-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy 48
MicroRNA-133 modulates the b1-adrenergic receptor transduction cascade 47
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 45
The Circulating Level of FABP3 Is an Indirect Biomarker of MicroRNA-1 43
An anti-PDGFR aptamer for selective delivery of small therapeutic peptide to cardiac cells 43
Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction 41
MicroRNA-133 controls cardiac myocyte hypertrophy 40
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice (vol 120, pg 2805, 2010) 39
Cardiovascular nanomedicine: The route ahead 39
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. 39
A comparative MudPIT analysis identifies different expression profiles in heart compartments. 37
Physiological myocardial hypertrophy: how and why? 36
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 36
The role of mitochondrial dynamics in cardiovascular diseases 36
Computational simulation of electromagnetic fields on human targets for magnetic targeting applications 36
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. 35
Biocompatible and inhalable antimicrobial-loaded nanoparticles for the counteraction of biofilm formation and antibiotic resistance: towards a potential new therapy for CF related infections 35
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 35
An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. 33
Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. 32
Role of electromagnetic stimulation on cardiac cells activity and on magnetic nanoparticles for drug delivery to the heart 32
FABP3 as a Biomarker of Heart Pathology 32
Genome-wide microRNA target gene identification and annotation using multiple prediction algorithms 32
The recent blooming of therapeutic aptamers 32
NF-kB mediated miR-26a regulation in cardiac fibrosis. 29
High Intensity Interval Training Ameliorates Mitochondrial Dysfunction in the Left Ventricle of Mice with Type 2 Diabetes 27
Akt regulates L-type Ca2+ channel activity by modulating Cava1 protein stability 27
Nano-Apatites with Designed Chemistry and Crystallinity for Bone Regeneration and Nanomedical Applications 26
Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt 26
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. 26
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 26
MicroRNAs: novel regulators in cardiac development and disease. 24
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. 24
Exercise training reverses myocardial dysfunction induced by CaMKII?C overexpression by restoring Ca2+ homeostasis. 23
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice 22
MicroRNAs and the control of heart pathophysiology 22
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs 21
HEXIM1: a new player in myocardial hypertrophy? 20
MiR-133a Regulates Collagen 1A1: Potential Role of miR-133a in Myocardial Fibrosis in Angiotensin II-Dependent Hypertension 20
Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy 20
AKT INCREASES SARCOPLASMIC RETICULUM CA2+ CYCLING BY DIRECT PHOSPHORYLATION OF PHOSPHOLAMBAN (PLN) AT THR17 19
MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension 19
APJ acts as a dual receptor in cardiac hypertrophy. 17
Cardiovascular inhalation for targeted drug delivery in cardiac disease 16
Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity 16
Totale 3.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.370
article - articoli 10.532
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 325
Totale 22.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 10 2
2024/20251.296 8 6 96 36 332 81 89 62 46 97 246 197
2025/20262.129 131 219 196 336 343 113 325 104 117 109 70 66
2026/202777 77 0 0 0 0 0 0 0 0 0 0 0
Totale 3.514